CLPT — Clearpoint Neuro Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Clearpoint Neuro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	54.1	37.5	23.1	20.1	45.9
Net Total Accounts Receivable
Net Total Receivables	2.34	2.67	3.21	4.71	7.26
Total Inventory
Prepaid Expenses
Total Current Assets	61.9	51.2	36.2	33.4	63.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.78	2.7	4.95	5.09	11.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	65.6	55.5	42.7	39.2	97.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.75	6.79	7.43	10.4	10.8
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	16.8	18.6	21.5	13.8	69.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	48.8	36.9	21.2	25.4	28
Total Liabilities & Shareholders' Equity	65.6	55.5	42.7	39.2	97.7
Total Common Shares Outstanding